Showing posts with label Osteoporosis. Show all posts
Showing posts with label Osteoporosis. Show all posts

Monday, October 14, 2013

Vitamin D pills' effect on healthy bones queried






Posted by Neill Abayon

Healthy adults do not need to take vitamin D supplements, suggests a study in The Lancet which found they had no beneficial effect on bone density, a sign of osteoporosis.

But experts say many other factors could be at play and people should not stop taking supplements.
University of Auckland researchers analysed 23 studies involving more than 4,000 healthy people.
The UK government recommends children and over-65s take a daily supplement.

The New Zealand research team conducted a meta-analysis of all randomised trials examining the effects of vitamin D supplementation on bone mineral density in healthy adults up to July 2012.

The supplements were taken for an average of two years by the study participants.

More here.



 

Thursday, September 2, 2010

Osteoporosis drug patients report bone fractures caused by drugs

Posted by Neill Abayon

Reports of bone fractures are widespread among patients taking osteoporosis drugs, a New York Times analysis of askapateint.com concludes.

"My mother was taking Fosamax from 1995 until 2005 for osteoporosis," one woman wrote in 2006. "She had severe esophageal ulcerations, nausea, jaw bone loss and vertigo from the inner ear. She was told to continue the drug. October 2005, she began to have trouble swallowing, she was initially told it was anxiety, but was then diagnosed with esophageal cancer and died nine months later in July 2006."

In 874 patient ratings since 2001, Merck's bisphosphonate Fosamax received an average rating of 1.5 out of 5. Procter & Gamble's Actonel has a rating of 1.5, while and Roche and GlaxoSmithKline's Boniva has a 1.3, the lowest of any drug on the site.

The average drug rating on askapatient.com is 3, "Somewhat satisfied." The lowest possible is 1, "Dissatisfied. I would not recommend taking this medication."

Read the full Article here.